Table of Contents
ISRN Hypertension
Volume 2013 (2013), Article ID 390109, 8 pages
http://dx.doi.org/10.5402/2013/390109
Research Article

Racial Disparity in the Associations of Microalbuminuria and Macroalbuminuria with Odds of Hypertension: Results from the NHANES Study in the United States

1Department of Biostatistics and Epidemiology at East Tennessee State University, 149H Lamb Hall, Johnson City, TN 37614, USA
2Institute for Quantitative Biology at East Tennessee State University, Johnson City, TN 37614, USA
3Department of Mathematics and Statistics at East Tennessee State University, Johnson City, TN 37614, USA
4Center on Patient Safety, Division of Health Affairs, Department of Family Medicine & Rural Health, College of Medicine at the Florida State University, Tallahassee, FL 32306, USA
5Department of Family Medicine & Rural Health, College of Medicine at the Florida State University, Tallahassee, FL 32306, USA

Received 23 October 2013; Accepted 14 November 2013

Academic Editors: Y. Iwashima and B. Waeber

Copyright © 2013 Xuefeng Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Z. Vokó, M. L. Bots, A. Hofman, P. J. Koudstaal, J. C. M. Witteman, and M. M. B. Breteler, “J-shaped relation between blood pressure and stroke in treated hypertensives,” Hypertension, vol. 34, no. 6, pp. 1181–1185, 1999. View at Google Scholar · View at Scopus
  2. F. A. El-Atat, S. N. Stas, S. I. Mcfarlane, and J. R. Sowers, “The relationship between hyperinsulinemia, hypertension and progressive renal disease,” Journal of the American Society of Nephrology, vol. 15, no. 11, pp. 2816–2827, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Rosendorff, H. R. Black, C. P. Cannon et al., “Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association council for high blood pressure research and the councils on clinical cardiology and epidemiology and prevention,” Circulation, vol. 115, no. 21, pp. 2761–2788, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. R. S. Vasan and D. Levy, “The role of hypertension in the pathogenesis of heart failure: a clinical mechanistic overview,” Archives of Internal Medicine, vol. 156, no. 16, pp. 1789–1796, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. M. N. Diringer, “Management of aneurysmal subarachnoid hemorrhage,” Critical Care Medicine, vol. 37, no. 2, pp. 432–440, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. A. S. Levey, J. Coresh, E. Balk, A. T. Kausz, A. Levin, and M. W. Steffes, “National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification,” Annals of Internal Medicine, vol. 139, pp. 137–147, 2003. View at Google Scholar · View at Scopus
  7. US Department of Health and Human Services, “Objective HDS-5. 1: reduce the proportion of adults with hypertension,” In Healthy People 2020, US Department of Health and Human Services, Washington, DC, USA, 2010, http://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicid=21.
  8. M. E. Molitch, R. A. DeFronzo, M. J. Franz et al., “Nephropathy in diabetes,” Diabetes Care, vol. 27, supplement 1, pp. S79–S83, 2004. View at Google Scholar · View at Scopus
  9. G. Eknoyan, T. Hostetter, G. L. Bakris et al., “Proteinuria and other markers of chronic kidney disease: a position statement of the National Kidney Foundation (NKF) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),” The American Journal of Kidney Diseases, vol. 42, no. 4, pp. 617–622, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. C. C. Hsu, F. L. Brancati, B. C. Astor et al., “Blood pressure, atherosclerosis, and albuminuria in 10 113 participants in the Atherosclerosis Risk in Communities study,” Journal of Hypertension, vol. 27, no. 2, pp. 397–409, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. R. J. Tapp, J. E. Shaw, B. Balkau et al., “Albuminuria is evident in the early stages of diabetes onset: results from the Australian diabetes, obesity, and lifestyle Study (AusDiab),” The American Journal of Kidney Diseases, vol. 44, no. 5, pp. 792–798, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. M. O. Ogunniyi, J. B. Croft, K. J. Greenlund, W. H. Giles, and G. A. Mensah, “Racial/ethnic differences in microalbuminuria among adults with prehypertension and hypertension: National Health and Nutrition Examination Survey (NHANES), 1999-2006,” The American Journal of Hypertension, vol. 23, no. 8, pp. 859–864, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Coresh, D. Byrd-Holt, B. C. Astor et al., “Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000,” Journal of the American Society of Nephrology, vol. 16, no. 1, pp. 180–188, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. A. H. Brantsma, S. J. L. Bakker, D. de Zeeuw, P. E. de Jong, and R. T. Gansevoort, “Urinary albumin excretion as a predictor of the development of hypertension in the general population,” Journal of the American Society of Nephrology, vol. 17, no. 2, pp. 331–335, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. J. P. Forman, N. D. L. Fisher, E. L. Schopick, and G. C. Curhan, “Higher levels of albuminuria within the normal range predict incident hypertension,” Journal of the American Society of Nephrology, vol. 19, no. 10, pp. 1983–1988, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. J. M. Flack, K. Duncan, S. E. Ohmit et al., “Influence of albuminuria and glomerular filtration rate on blood pressure response to antihypertensive drug therapy,” Vascular Health and Risk Management, vol. 3, no. 6, pp. 1029–1037, 2007. View at Google Scholar · View at Scopus
  17. I. Hajjar and T. A. Kotchen, “Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000,” Journal of the American Medical Association, vol. 290, no. 2, pp. 199–206, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. M. J. Glover, K. J. Greenlund, C. Ayala, and J. B. Croft, “Racial/ethnic disparities in prevalence, treatment, and control of hypertension,” Journal of the American Medical Association, vol. 293, no. 8, pp. 923–925, 2005. View at Google Scholar
  19. S. Y. Angell, R. K. Garg, R. C. Gwynn, L. Bash, L. E. Thorpe, and T. R. Frieden, “Prevalence, awareness, treatment, and predictors of control of hypertension in New York City,” Circulation, vol. 1, no. 1, pp. 46–53, 2008. View at Google Scholar · View at Scopus
  20. Centers for Disease Control and Prevention (CDC) and National Center for Health Statistics (NCHS), “National Health and Nutrition Examination Survey Data,” Department of Health and Human Services, Centers for Disease Control and Prevention, Hyattsville, Md, USA, 1999–2008http://www.cdc.gov/nchs/nhanes.htm.
  21. L. A. Stevens, J. Coresh, T. Greene, and A. S. Levey, “Assessing kidney function: measured and estimated glomerular filtration rate,” The New England Journal of Medicine, vol. 354, no. 23, pp. 2473–2483, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. X. Liu, M. Liu, D. Tsilimingras, and E. L. Schiffrin, “Racial disparities in cardiovascular risk factors among diagnosed hypertensive subjects,” Journal of the American Society of Hypertension, vol. 5, no. 4, pp. 239–248, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. H. M. Cruz, A. B. Cruzera, and J. Cruz, “Microalbuminuria in essential hypertensives in treatment for hypertension,” Revista do Hospital das Clínicas, vol. 52, no. 5, pp. 258–262, 1997. View at Google Scholar · View at Scopus
  24. W. F. Keane, G. Eknoyan, and K. Willis, “Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation,” The American Journal of Kidney Diseases, vol. 33, no. 5, pp. 1004–1010, 1999. View at Google Scholar · View at Scopus
  25. M. R. Weir, “Microalbuminuria and cardiovascular disease,” Clinical Journal of the American Society of Nephrology, vol. 2, no. 3, pp. 581–590, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. National Kidney Foundation, “K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification,” The American Journal of Kidney Diseases, vol. 39, no. 2, supplement 1, pp. S1–S266, 2002. View at Google Scholar
  27. A. W. Cowley Jr. and R. J. Roman, “The role of the kidney in hypertension,” Journal of the American Medical Association, vol. 275, no. 20, pp. 1581–1589, 1996. View at Google Scholar · View at Scopus
  28. R. Rettig and O. Grisk, “The kidney as a determinant of genetic hypertension: evidence from renal transplantation studies,” Hypertension, vol. 46, no. 3, pp. 463–468, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. C. A. Peralta, Y. Li, C. Wassel et al., “Differences in albuminuria between Hispanics and whites: an evaluation by genetic ancestry and country of origin: the multi-ethnic study of atherosclerosis,” Circulation, vol. 3, no. 3, pp. 240–247, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. S. E. Jolly, N. R. Burrows, S.-C. Chen et al., “Racial and ethnic differences in albuminuria in individuals with estimated GFR greater than 60 mL/min/1.73 m2: results from the kidney early evaluation program (KEEP),” The American Journal of Kidney Diseases, vol. 55, supplement 3, pp. S15–S22, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. “Cholesterol Statistics,” American Heart Association, 2008, http://www.americanheart.org/presenter.jhtml?identifier=536.
  32. J. C. Celentano, “Increased fruit and vegetable intake may reduce the nutrition-related health disparities in African Americans,” The American Journal of Lifestyle Medicine, vol. 3, pp. 185–187, 2009. View at Google Scholar
  33. P. Ochodnicky, R. H. Henning, R. P. E. van Dokkum, and D. de Zeeuw, “Microalbuminuria and endothelial dysfunction: emerging targets for primary prevention of end-organ damage,” Journal of Cardiovascular Pharmacology, vol. 47, supplement 2, pp. S151–S162, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Rossi, E. Chiurlia, A. Nuzzo, E. Cioni, G. Origliani, and M. G. Modena, “Flow-mediated vasodilation and the risk of developing hypertension in healthy postmenopausal women,” Journal of the American College of Cardiology, vol. 44, no. 8, pp. 1636–1640, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Y. Wong, A. Shankar, R. Klein, B. E. K. Klein, and L. D. Hubbard, “Prospective cohort study of retinal vessel diameters and risk of hypertension,” British Medical Journal, vol. 329, no. 7457, pp. 79–82, 2004. View at Google Scholar · View at Scopus
  36. L. Kalinowski, I. T. Dobrucki, and T. Malinski, “Race-specific differences in endothelial function: predisposition of African Americans to vascular diseases,” Circulation, vol. 109, no. 21, pp. 2511–2517, 2004. View at Publisher · View at Google Scholar · View at Scopus